NGL is a market leader in veterinary APIs, supplying essential actives across key therapeutic categories worldwide.
| Product Name | CAS NO | Therapeutic Category | Regulatory Status | |||
|---|---|---|---|---|---|---|
| DMF | EU ASMF | CEP | US VMF | |||
Afoxolaner*VIEW |
1093861-60-9 | Anti - Ticks & Anti - Fleas | ✓ | - | - | Planned |
AmitrazVIEW |
33089-61-1 | Ectoparasiticide | ✓ | ✓ | - | - |
AtovaquoneVIEW |
95233-18-4 | Antiprotozoal | ✓ | - | - | - |
BuparvaquoneVIEW |
88426-33-9 | Antiprotozoal | ✓ | - | - | - |
ButaphosphanVIEW |
17316-67-5 | Phosphorous Supplement | ✓ | ✓ | - | Planned |
CarprofenVIEW |
53716-49-7 | NSAID | ✓ | - | Filed | Filed |
ClorsulonVIEW |
60200-06-8 | Anthelmintic | ✓ | ✓ | - | Filed |
Closantel BaseVIEW |
61438-64-0 | Anthelmintic | ✓ | Planned | - | - |
Closantel SodiumVIEW |
61438-64-0 | Anthelmintic | ✓ | - | Planned | - |
DecoquinateVIEW |
18507-89-6 | Antiprotozoal – Coccidiostat | ✓ | - | - | - |
Diminazene DiaceturateVIEW |
908-54-3 | Antiprotozoal | ✓ | - | - | - |
FebantelVIEW |
58306-30-2 | Anthelmintic | ✓ | - | Filed | Planned |
FenbendazoleVIEW |
43210-67-9 | Anthelmintic | ✓ | - | Filed | Planned |
FluazuronVIEW |
86811-58-7 | Antiparasitic – Insect Growth Regulator | ✓ | - | - | - |
FlumethrinVIEW |
69770-45-2 | Ectoparasiticide | ✓ | Planned | - | - |
Flunixin MeglumineVIEW |
42461-84-7 | NSAID | ✓ | - | ✓ | Filed |
Fluralaner*VIEW |
864731-61-3 | Anti - Ticks & Anti - Fleas | ✓ | - | - | Planned |
Halquinol (98% & 60%)VIEW |
8067-69-4 | Growth Promoter | ✓ | - | - | - |
Homidium ChlorideVIEW |
602-52-8 | Antiprotozoal | ✓ | - | - | - |
Imidocarb DipropionateVIEW |
55750-06-6 | Antiprotozoal | ✓ | ✓ | - | - |
Isometamidium Chlroide HClVIEW |
6798-24-9 | Antiprotozoal | ✓ | - | - | - |
Lotilaner*VIEW |
1362334-54-3 | Anti - Ticks & Anti - Fleas | ✓ | - | - | - |
MarbofloxacinVIEW |
115550-35-1 | Anti-Bacterial | ✓ | - | ✓ | Planned |
Maropitant Citrate MonohydrateVIEW |
158861-67-7 | Anti-Emetic | ✓ | - | - | Planned |
Meglumine (N-Methyl-D-Glucamine)VIEW |
6284-40-8 | Excipient | ✓ | - | Planned | - |
N-Ethyl-D-Glucamine (Eglumine)VIEW |
1852-39-5 | Excipient | Tech-Pack | - | - | - |
NitroscanateVIEW |
55981-09-4 | Anthelmintic | ✓ | - | - | - |
NitroxynilVIEW |
1689-89-0 | Anthelmintic | ✓ | - | - | - |
Oclacitinib maleate*VIEW |
1208319-26-9 | Anti-Dermatitis / Anti-Itching | ✓ | - | - | - |
OxfendazoleVIEW |
53716-50-0 | Anthelmintic | ✓ | - | - | - |
ParvaquoneVIEW |
4042-30-2 | Antiprotozoal | ✓ | - | - | - |
PermethrinVIEW |
52645-53-1 | Ectoparasiticide | ✓ | - | - | - |
PhenazoneVIEW |
60-80-0 | Anti-Pyretic | ✓ | - | - | - |
PonazurilVIEW |
69004-03-1 | Antiprotozoal – Coccidiostat | ✓ | - | - | Planned |
PraziquantelVIEW |
55268-74-1 | Anthelmintic | ✓ | Filed | Filed | Planned |
Ractopamine HCLVIEW |
90274-24-1 | Growth Promoter | ✓ | - | - | Planned |
RafoxanideVIEW |
22662-39-1 | Anthelmintic | ✓ | - | - | - |
Ricobendazole (Albendazole Sulphoxide)VIEW |
54029-12-8 | Anthelmintic | ✓ | - | - | - |
R-PraziquantelVIEW |
55268-74-1 | Anthelmintic | ✓ | - | - | - |
Sarolaner*VIEW |
1398609-39-6 | Anti - Ticks & Anti - Fleas | ✓ | - | - | - |
S-MethopreneVIEW |
65733-16-6 | Antiparasitic – Insect Growth Regulator | ✓ | ✓ | - | - |
Toldimfos SodiumVIEW |
575-75-7 | Phosphorous Supplement | ✓ | ✓ | - | - |
ToltrazurilVIEW |
69004-03-1 | Antiprotozoal – Coccidiostat | ✓ | - | - | - |
TriclabendazoleVIEW |
68786-66-3 | Anthelmintic | ✓ | - | ✓ | - |
Xylazine BaseVIEW |
7361-61-7 | Analgesic & Anesthetic | ✓ | - | - | - |
Xylazine HClVIEW |
23076-35-9 | Analgesic & Anesthetic | ✓ | - | Filed | Planned |
ZilpaterolVIEW |
99200-09-6 | Growth Promoter | ✓ | - | - | Planned |
Disclaimer*
NGL FINE CHEM LIMITED is committed to protect the intellectual property (IP) generated in house and equally committed to respect the IP rights of all entities. Certain pipeline products may have valid patent(s) by other in India and/or in other jurisdictions. NGL offers such patented products for research and testing purpose only. The buyer will have the exclusive responsibility to respect the third party patent rights whether related to product or process.
